KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Return on Invested Capital (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Return on Invested Capital for 11 consecutive years, with 0.05% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital fell 10.0% to 0.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.05% through Dec 2025, down 10.0% year-over-year, with the annual reading at 0.05% for FY2025, 10.0% down from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.05% at Supernus Pharmaceuticals, down from 0.03% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.15% in Q1 2021, with the low at 0.05% in Q4 2025.
  • Average Return on Invested Capital over 5 years is 0.04%, with a median of 0.05% recorded in 2025.
  • The sharpest move saw Return on Invested Capital decreased -10bps in 2021, then increased 8bps in 2025.
  • Over 5 years, Return on Invested Capital stood at 0.06% in 2021, then crashed by -31bps to 0.04% in 2022, then crashed by -106bps to 0.0% in 2023, then soared by 2386bps to 0.06% in 2024, then tumbled by -179bps to 0.05% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.05%, 0.03%, and 0.05% for Q4 2025, Q3 2025, and Q2 2025 respectively.